5 Star
.
.
Alicia Farmer
.
.

Baumhefner said for many patients with breakthrough disease on standard IFNβ-1a, increasing the treatment dosage with twice-weekly therapy may be an acceptable alternative to switching treatments.

June Halper, MSN, MSCN, CMCS CEO, agreed, noting that "it makes a lot of sense for some patients to stay on a drug that has worked for them, and tweak the therapy if there is a breakthrough instead of automatically moving on to another drug," she told MedPage Today.

Baumhefner said a prospective, blinded, randomized trial comparing once-weekly and twice-weekly intramuscular IFNβ-1a may be warranted.

.
.
Fred Slape after brain surgery
. http://game-rapidshare.com/Killette-grandma-of-Mcilhinney-from-Gujrat?Muncriefd=172
.
.
. .
Does the brain store information in discrete or analog form?

New evidence in favor of a discrete form of data storage could change the way we understand the brain and the devices we build to interface with it.

.
.